During the past decade, AIDS Research Initiative conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "AIDS Research Initiative" #1 collaborator was "Abbott" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator and "AIDS Council of New South Wales" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "AIDS Research Initiative" are "HIV Infection" (1 trials), "HIV Infections" (1 trials) and "HIV-Associated Lipodystrophy" (1 trials). Many other conditions were trialed in "AIDS Research Initiative" in a lesser frequency.

Most popular intervention types in "AIDS Research Initiative" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "HIV drug resistance tests based upon genotype testing" (1 trials) and "poly-L-lactic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "AIDS Research Initiative" are 2 trials for "All" genders.

Currently, there are NaN active trials in "AIDS Research Initiative". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in AIDS Research Initiative, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in AIDS Research Initiative, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".